Back to search
FDAFDA · Food and drugs·Recall number D-0654-2022

Alprazolam Tablets, USP 1mg, 180-count bottles, Rx only, Manufactured by ULTRAlab Laboratories, Inc., NY; Packaged by GSMS, Inc., CA NDC 60429-504-18.

Published March 23, 2022 · Recall initiated: March 2, 2022

Summary

FDA records drug Class II recall D-0654-2022, published March 23, 2022 and initiated March 2, 2022. Recalling firm: Golden State Medical Supply Inc.; Status: Terminated; Reported quantity: 401 bottles; Lot: Lot #: GS027852, Expiry: 06/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviation: Potential cross-contamination with other drug substance during the manufacturing process.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Golden State Medical Supply Inc.
Distributor
Distributed to 1 wholesaler/distributor
Lot
Lot #: GS027852, Expiry: 06/2022.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Alprazolam Tablets, USP 1mg, 180-count bottles, Rx only, Manufactured by ULTRAlab Laboratories, Inc., NY; Packaged by GSMS, Inc., CA NDC 60429-504-18. recalled?

Yes. FDA published recall D-0654-2022 on March 23, 2022. Reported hazard: CGMP Deviation: Potential cross-contamination with other drug substance during the manufacturing process.

What should I do if I have this product?

Voluntary: Firm initiated · Letter